TrademarkDir
OXYSTEROL THERAPEUTICS
LIVE

Serial Number

86746639

Owner

MAX BioPharma, Inc.

Filing Date

Sep 3, 2015

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

OXYSTEROL THERAPEUTICS Trademark

Serial Number: 86746639 • Registration: 5152047

OXYSTEROL THERAPEUTICS is a trademark filed by MAX BioPharma, Inc. on September 3, 2015. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

MAX BioPharma, Inc. (4 trademarks)

612 South Barrington Ave., Ste 212
Los Angeles, CA 90049

Entity Type: 03

Trademark Details

Filing Date

September 3, 2015

Registration Date

February 28, 2017

Published for Opposition

March 1, 2016

Goods & Services

Therapeutic pharmaceutical for the treatment of osteoporosis, localized bone formation conditions, for use in oncology

Filing History

NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
Aug 19, 2025 NURC
CORRECTION UNDER SECTION 7 - PROCESSED
Jul 31, 2025 COC.
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Apr 10, 2025 ERRR
POST REGISTRATION ACTION CORRECTION
Apr 8, 2025 XXXX
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Apr 7, 2025 EROP
POST REGISTRATION ACTION MAILED - SEC. 7
Oct 7, 2024 PRAM
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Sep 26, 2024 EROP
POST REGISTRATION ACTION MAILED - SEC. 7
Apr 15, 2024 PRAM
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Apr 8, 2024 APRE
TEAS SECTION 7 REQUEST RECEIVED
Aug 29, 2023 ES7R
TEAS SECTION 8 RECEIVED
Aug 25, 2023 ES8R
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Feb 28, 2022 REM1
REGISTERED-PRINCIPAL REGISTER
Feb 28, 2017 R.PR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 25, 2017 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 25, 2017 REAP
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jan 24, 2017 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jan 23, 2017 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 19, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 19, 2017 CRFA
ASSIGNED TO LIE
Jan 19, 2017 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 19, 2016 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 29, 2016 GNRN
NON-FINAL ACTION E-MAILED
Jun 29, 2016 GNRT
SU - NON-FINAL ACTION - WRITTEN
Jun 29, 2016 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Jun 24, 2016 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jun 23, 2016 AITU
USE AMENDMENT FILED
May 31, 2016 IUAF
TEAS STATEMENT OF USE RECEIVED
May 31, 2016 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 26, 2016 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 1, 2016 NPUB
PUBLISHED FOR OPPOSITION
Mar 1, 2016 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 10, 2016 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 4, 2016 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 30, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 29, 2015 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 29, 2015 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 18, 2015 GNRN
NON-FINAL ACTION E-MAILED
Dec 18, 2015 GNRT
NON-FINAL ACTION WRITTEN
Dec 18, 2015 CNRT
ASSIGNED TO EXAMINER
Dec 16, 2015 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 9, 2015 NWOS
NEW APPLICATION ENTERED
Sep 7, 2015 NWAP

Related Trademarks

More from this Owner

MAX BIOPHARMA

MAX BIOPHARMA

MAX BIOPHARMA

MAX BIOPHARMA

MAX BIOPHARMA

MAX BIOPHARMA

OXYFUSE-133

OXYFUSE-133

OXYFUSE-133

OXYFUSE-133

MAXBIOPHARMA

MAXBIOPHARMA